Divisas / SNY
SNY: Sanofi - American Depositary Shares
49.48
USD
0.46
(0.92%)
El tipo de cambio de SNY de hoy ha cambiado un -0.92%. En este caso, el precio mínimo en el mercado ha alcanzado 49.25, mientras que el máximo ha alcanzado 49.74.
Siga la dinámica de la pareja de divisas Sanofi - American Depositary Shares. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
SNY News
- AbbVie Smashes Earnings, Bets Big On Depression Drug Bretisilocin
- Will Weak Gardasil Sales Continue to Be a Drag on MRK's Top Line?
- BofA downgrades Novavax stock on vaccine uncertainty
- Macquarie Small Cap Core Fund Q2 2025 Commentary
- Recursion: "Hold" Rating Based On Initial REC-4881 FAP Treatment Data (NASDAQ:RXRX)
- Columbia Pyrford International Stock Fund Q2 2025 Commentary (Mutual Fund:PISOX)
- Macquarie Smid Cap Core Fund Q2 2025 Commentary
- Solar, biotech, and health insurance stocks are moving on Friday: here's why
- Can Eylea HD and Dupixent Profits Revive Regeneron Stock?
- SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease
- H.C. Wainwright lowers Adagene stock price target to $7 on development path clarity
- BNY Mellon Global Equity Income Fund Q2 2025 Commentary
- Bicycle Therapeutics stock price target lowered to $10 at Citizens JMP
- Sanofi halts Praluent supply in China due to limited availability
- Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca Face Renewed Claims Of Conspiring To Restrict 340B Discounts - AstraZeneca (NASDAQ:AZN), Novo Nordisk (NYSE:NVO), Eli Lilly (NYSE:LLY), Sanofi (NASDAQ:SNY)
- AstraZeneca: Great Portfolio, But Not A Great Price (NASDAQ:AZN)
- Bicycle Therapeutics stock price target raised to $27 from $25 at RBC Capital
- Kymera Q2 2025 slides: Strong pipeline advances despite revenue decline
- Recordati shares rise after Jefferies upgrade to “buy” on growth prospects
- Arrowhead Pharma stock price target lowered to $21 at Leerink Partners
- Chardan Capital lowers SAB Biotherapeutics stock price target to $12 from $20
- This Monster Beverage Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday - Monster Beverage (NASDAQ:MNST), LegalZoom.com (NASDAQ:LZ)
- JPMorgan upgrades Sanofi stock rating to Overweight on favorable pipeline outlook
- Ariel International Fund Q2 2025 Commentary
Rango diario
49.25
49.74
Rango anual
44.73
59.73
- Cierres anteriores
- 49.94
- Open
- 49.40
- Bid
- 49.48
- Ask
- 49.78
- Low
- 49.25
- High
- 49.74
- Volumen
- 5.823 K
- Cambio diario
- -0.92%
- Cambio mensual
- 7.61%
- Cambio a 6 meses
- -12.07%
- Cambio anual
- -14.35%
30 agosto, sábado